Multimodality imaging in hypertrophic cardiomyopathy

Authors

Matthew Peters, Advocate Health - MidwestFollow
McKenzie Schweitzer, Advocate Health - MidwestFollow
Patrycja Galazka, Advocate Health - MidwestFollow

Recommended Citation

Peters M, Schweitzer M, Galazka P. Multimodality Imaging in Hypertrophic Cardiomyopathy. Cardiol Clin. 2026;44(1):81-95. doi:10.1016/j.ccl.2025.07.007

Affiliations

Aurora Sinai/Aurora St. Luke's Medical Centers

Abstract

The diagnosis and management of hypertrophic cardiomyopathy (HCM) requires accurate and comprehensive imaging. Advances in imaging technology and clinical understanding have significantly enhanced the ability to characterize the phenotype, assess risk, monitor disease progression, and guide therapy. This article highlights the complementary roles of echocardiography, cardiac magnetic resonance, computed tomography, and nuclear imaging in the evaluation of HCM and explores emerging research and innovation that are shaping future diagnostic and therapeutic strategies.

Type

Article

PubMed ID

41242777